Moffitt logo
calledFromCancerPage=False - substr=
testProtocol=

Clinical Trials Search

Search Results:

Order By: 

Showing of 50

CLINICAL TRIAL 19322

A Phase 1b Trial of Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination with Azacitidine in Patients with Hematological Malignancies

Disease Site: Leukemia, not otherwise specified, Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS)

View Trial Details

CLINICAL TRIAL 19635

A Phase 1b/2 Study Evaluating the Safety and Efficacy of Intravenous LB-100 in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) who had Disease Progression or are Intolerant to Prior Therapy

Disease Site: Leukemia, other, Myelodysplastic syndrome (MDS)

View Trial Details

CLINICAL TRIAL 19658

A Phase 1, Open-Label, Dose-Escalation with Expansion Study of SX-682 in Subjects with Myelodysplastic Syndrome Who Had Disease Progression or are Intolerant to Prior Therapy

Disease Site: Leukemia, not otherwise specified, Leukemia, other, Myelodysplastic syndrome (MDS)

View Trial Details

CLINICAL TRIAL 19862

A Phase 1/1b Safety Study of PRGN-3006 Adoptive Cellular Therapy in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome

Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS), Myeloid and Monocytic Leukemia

View Trial Details

CLINICAL TRIAL 19872

A Phase 3, Open-Label, Randomized Study To Compare The Efficacy And Safety Of Luspatercept (Ace-536) Versus Epoetin Alfa for the Treatment Of Anemia Due To IPSS-R Very Low, Low Or Intermediate Risk Myelodysplastic Syndromes (Mds) In Esa Naïve Subjects Who Require Red Blood Cell Transfusions The Commands Trial

Disease Site: Myeloid and Monocytic Leukemia, Myelodysplastic syndrome (MDS)

View Trial Details

CLINICAL TRIAL 20042

CD8 Depleted, Non-Engrafting, HLA Mismatched Unrelated Donor Lymphocyte Infusion in Patients with MDS and Secondary AML

Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS), Myeloid and Monocytic Leukemia

View Trial Details

CLINICAL TRIAL 20126

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (CTRL-ALT-D)

Disease Site: Non-Hodgkin's Lymphoma, Myeloid and Monocytic Leukemia, Leukemia, other, Hodgkin's Lymphoma, Lymphoid Leukemia, Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS), NHL - Anaplastic large cell lymphoma (ALCL), NHL - Burkitt's lymphoma, NHL - Diffuse large cell lymphoma, NHL - lymphoblastic lymphoma, Other leukemia

View Trial Details
;